Tinnitus clinical trials

Explore recruiting tinnitus clinical trials.

Recruiting tinnitus studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Tinnitus trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

TINNITOX - Botulinum toxin A in tinnitus patients with concurrent bruxism and/or jaw muscle myalgia. A triple blind, randomized, placebo-controlled cross-over trial.

Norway

Therapeutic confirmatory (Phase III) EU CTIS Study details

A multicenter, double-blinded, randomized, placebo-controlled trial to compare the effectiveness of intratympanic injections methylPREDnisolone versus placebo in the treatment of vertigo attacks in MENière’s disease (PREDMEN trial).

Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

Intracochlear Triamcinolone acetonide in sudden sensorineural hearing loss patients - a prospective observer blinded randomized study

Austria

Therapeutic exploratory (Phase II) EU CTIS Study details

Phase IIa randomized, double-blind, and placebo-controlled multicenter split body trial to determine safety, tolerability, and efficacy of repeated doses of ACOU085 for the prevention of hearing loss in testicular cancer patients receiving cisplatin

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

A Multicenter, Two-arm, Double-blind, Double dummy, Parallel-group Study for efficacy and safety evaluation of prolonged release formulation of Betahistine PR 48 mg once daily in comparison with conventional release formulation of Betahistine IR 24 mg, twice daily in treatment of adult patients with Menière's disease

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Effect of intravenous Lidocaine bolus on the median effective concentration (EC50) of Propofol during target controlled infusion (TCI : Schnider model) for gastroscopy in adult patients : a prospective, randomized, double-blinded study

Belgium

Therapeutic use (Phase IV) EU CTIS Study details

Tinnitus trials by city

Tinnitus in Toronto Tinnitus in Vancouver Tinnitus in Montreal Tinnitus in Calgary Tinnitus in Edmonton Tinnitus in Ottawa Tinnitus in Winnipeg Tinnitus in Quebec City Tinnitus in Hamilton Tinnitus in Kitchener Tinnitus in London Tinnitus in Halifax Tinnitus in New York Tinnitus in Los Angeles Tinnitus in Chicago Tinnitus in Houston

Other conditions

Hepatitis B Hepatitis C COVID-19 Influenza RSV Sickle cell disease Anemia Hemophilia Thalassemia Chronic pain Low back pain Smoking cessation Hearing loss Chronic fatigue syndrome Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS